← Patent-cliff monitor small molecule NOXAFIL POSACONAZOLE
Loss of exclusivity February 2033 latest FDA-listed patent expiry
Company MERCK SHARP AND DOHME CORP
Drug detail Brand name NOXAFIL Active ingredient POSACONAZOLE Strength 300MG/16.7ML (18MG/ML) Dosage form SOLUTION Route INTRAVENOUS Modality Small molecule FDA approval March 2014 Marketing status DISCN
Listed patents Patent Expires Type 9493582 February 2033 product 9023790 July 2031 product 9358297 June 2031 product 9750822 March 2029 product 10117951 March 2029 product 8410077 March 2029 product
Regulatory exclusivity Code Expires NPP January 2029 ODE-355 June 2028
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.